A Multidisciplinary Exploration of Complexities and Controve

Name: A Multidisciplinary Exploration of Complexities and Controversies in Thyroid Eye Disease: Spotlight on Treatment and Management
Uploaded: 2024-10-30T04:00:00+00:00
Description: Are we on the same page when it comes to TED? Program Chair Prem S. Subramanian, MD, PhD , and an expert panel of oculoplastic surgeons,

Overview
Are we on the same page when it comes to TED?
Program Chair Prem S. Subramanian, MD, PhD, and an expert panel of oculoplastic surgeons, neuro-ophthalmologists, endocrinologists, and comprehensive ophthalmologists address this question and delve into the contentious and evolving landscape of TED management. Watch this dynamic multidisciplinary dialogue that will explore the associated challenges, controversies, and practice patterns of TED, as well as the intricacies of TED treatment.

This activity is supported by an independent educational grant from Amgen.
Learning Objectives
Upon completion of this activity, the participant should be able to:
- Define indications for medical and biologic therapies in TED
- Evaluate the changing role of surgical intervention in patients with thyroid eye disease
- Apply an evidence-based approach to perform risk-benefit assessments for patients with TED and adapt management plans as risk-benefit profiles evolve
- Establish screening and monitoring protocols that ensure appropriate patient selection and maximize successful outcomes with biologic therapies
- Develop strategies for effective co-management that prioritizes multidisciplinary care and shared decision-making with patients
Accreditation
Provided by Evolve Medical Education
Evolve is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Evolve designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Participation Method
In order to obtain credit, proceed through the program, complete the posttest, evaluation and submit for credit.
Faculty and Disclosures
Prem S. Subramanian, MD, PhD
Clifford R. and Janice N. Merrill
Endowed Chair in Ophthalmology
Professor of Ophthalmology, Neurology,
and Neurosurgery
Vice Chair for Academic Affairs
Sue Anschutz-Rodgers
University of Colorado Eye Center
Aurora, CO

Raymond Cho, MD, FACS
Clinical Professor and Director, Ophthalmic Plastic and Reconstructive Surgery
The Ohio State University
Wexner Medical Center
Columbus, OH

Sonalika Khachikian, MD
Department Chair
Division of Endocrinology
Monument Health Rapid City Clinic
Rapid City, SD

Christian Nasr, MD
University of Arizona
College of Medicine – Phoenix
Banner University Medical Center
Phoenix, AZ

Lisa M. Nijm, MD, JD
Founder & Medical Director
Warrenville EyeCare and LASIK
Warrenville, IL
Assistant Clinical Professor of Ophthalmology
University of Illinois Eye and Ear Infirmary
Director, RealWorldOphthalmology.com
Chicago, IL

Madhura Tamhankar, MD
Associate Professor of Ophthalmology, Neuro-ophthalmology, and Adult Strabismus
Scheie Eye Institute
University of Pennsylvania
Philadelphia, PA

Sara Tullis Wester, MD
Professor of Clinical Ophthalmology
Oculofacial Plastic and
Reconstructive Surgery
Orbital Surgery and Oncology
Bascom Palmer Eye Institute
University of Miami Miller School of Medicine
Miami, FL

DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all financial relationships prior to this educational activity.
The following faculty/staff members have the following financial relationships with ineligible companies.
Prem S. Subramanian, MD, PhD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Acelyrin, Alexion, GenSight Biologics, Horizon Therapeutics, Invex Therapeutics, Kriya Therapeutics, Neurophth Therapeutics, Tourmaline Bio, and Viridian Therapeutics. Grant/Research Support: Department of Defense, Horizon Therapeutics, and National Institutes of Health. Independent Contractor: GenSight Biologics, Horizon Therapeutics, Immunovant, Invex Therapeutics, Neurophth Therapeutics, Tourmaline Bio, and Viridian Therapeutics.
Raymond Cho, MD, FACS, has had no financial relationships or affiliations with ineligible companies.
Sonalika Khachikian, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Amgen and Amneal Pharmaceuticals. Speaker's Bureau: Amgen.
Christian Nasr, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Horizon Therapeutics and Nevro Corp.
Lisa M. Nijm, MD, JD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Alcon, Allergan, Azura Ophthalmics, Bausch + Lomb, BVI Medical, Carl Zeiss Meditec, Centricity Vision, Dompe, Harrow, Horizon Therapeutics, Iveric Bio, Johnson & Johnson Vision, Nordic Pharma, Ocular Therapeutix, Orasis, Rayner, Scope Health, Sun Ophthalmics, Tarsus, Théa, TruKera Medical, Viatris, and Visus Therapeutics. Speaker's Bureau: Allergan, Bausch + Lomb, Horizon Therapeutics, Johnson & Johnson Vision, Ocular Therapeutix, Sun Ophthalmics, and Viatris. Grant/Research Support: Ocular Therapeutix. Stock Options: TruKera Medical.
Madhura Tamhankar, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Amgen, Genentech, and Viridian Therapeutics.
Sara Tullis Wester, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Horizon, Immunovant, Lassen, and Vasaragen/Sling. Grant/Research Support: Horizon, Immunovant, and Vasaragen/Sling.
The Evolve staff, planners and peer reviewer have no financial relationships with ineligible companies.
Disclaimer
OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Amgen.
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
System Requirements
- Supported Browsers (2 most recent versions):
- Google Chrome for Windows, Mac OS, iOS, and Android
  Apple Safari for Mac OS and iOS
  Mozilla Firefox for Windows, Mac OS, iOS, and Android
  Microsoft Edge for Windows
- Recommended Internet Speed: 5Mbps+
Publication Dates
Release Date: 10/30/2024
Expiration Date: 10/30/2025